Registered Nurse in Franklin, IN Accepting Medicare
5 Registered Nurse nurses found. Showing 1 - 5
 Donna Pluntz, R.N. Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 1178 N Main St, Franklin, IN 46131 Phone: 317-501-2116 |
Amanda L Harmon, APRN, WHNP-BC, IBCLC Registered Nurse - Lactation Consultant Medicare: Medicare Enrolled Practice Location: 1125 W Jefferson St Ste S200, Franklin, IN 46131 Phone: 317-736-0630 Fax: 317-738-0737 |
Patricia Elaine Hill, RN BSN Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 1125 W Jefferson St, Franklin, IN 46131 Phone: 317-736-3300 |
 Jeremy Jack Headlee, RN Registered Nurse - Case Management Medicare: Not Enrolled in Medicare Practice Location: 1220 N Lakeview Cir Apt G, Franklin, IN 46131 Phone: 317-642-6097 |
Casey Ann Burns, FNP-C Registered Nurse Medicare: Medicare Enrolled Practice Location: 1159 W Jefferson St Ste 206, Franklin, IN 46131 Phone: 317-738-4430 Fax: 317-738-4405 |
News Archive
Apple Watch ECG app may detect coronary ischemia
Digitization can do a lot in medicine, even save lives. This is shown by the specific case of an 80-year-old patient in Mainz.
Anesthetics during breast cancer surgery may affect development of chronic pain
In women with breast cancer, the choice of anesthetic used for mastectomy may affect the risk of developing long-term pain after surgery, according to a study in the March issue of Anesthesia & Analgesia, official journal of the International Anesthesia Research Society (IARS).
Johns Hopkins researchers discover new way to treat triple-negative breast cancer
Triple-negative breast cancer is as bad as it sounds. The cells that form these tumors lack three proteins that would make the cancer respond to powerful, customized treatments. Instead, doctors are left with treating these patients with traditional chemotherapy drugs that only show long-term effectiveness in 20 percent of women with triple-negative breast cancer.
A.P. Pharma submits NDA for APF530 in chemo-induced nausea and vomiting
A.P. Pharma, Inc. has announced that it has submitted a New Drug Application (NDA) for its lead product, APF530, to the U.S. Food and Drug Administration (FDA). APF530 is being developed for the prevention of chemotherapy-induced nausea and vomiting (CINV) and is a long-acting formulation of granisetron that utilizes the Company's proprietary Biochronomer drug delivery system.
› Verified 1 days ago
Nurse Practitioner
Physician Assistant
Registered Nurse
Nurse Anesthetist - CR